Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2025-12-24 @ 2:24 PM
NCT ID:
NCT04181359
Eligibility Criteria:
Inclusion Criteria:
* ILD participants free of any significant cardiovascular, metabolic or neuromuscular disease. Specific criteria are:
* Established physician diagnosis of ILD
* Forced vital capacity 50-80 % predicted
* Diffusing capacity for carbon monoxide 35-60 % predicted
* Able to complete a 6-minute walk test
* Participants will range from 18-85 years old.
* There are no restrictions on pulmonary medications, however, participants will be asked to withdraw from long-acting beta agonists 48 hours prior to trials.
Exclusion Criteria:
* Participants with current or previous history of myocardial infarction or angina pectoris will be excluded.
* Participants with a lowest arterial oxygen saturation \< 84% during the initial CPET (day 1) on room air will be excluded.
* Patient receiving treatment for isosorbide mononitrate or pulmonary arterial hypertension (PAH) medications will be excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT04181359
Study Brief:
Protocol Section:
NCT04181359